Newsroom

The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

89% quieter: The new QuietAir diffuser vent for AirFit F20 and AirTouch F20 masks

Read the press release

89% quieter: The new QuietAir diffuser vent for AirFit F20 and AirTouch F20 masks

Read the press release

Latest news

Latest news

September 18, 2018

PARIS – 18 September 2018 – Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s...

September 13, 2018

SAN DIEGO – September 13, 2018 – ResMed (NYSE: RMD, ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio,...

September 6, 2018

SPRINGFIELD, MO -- Sept. 6, 2018 -- HEALTHCAREfirst, a leading provider of web-based home health and hospice software, billing and coding services, CAHPS surveys, and advanced analytics, announced...

See all news releases

Fast facts - Landing Page

Fast facts

  • +1 MILLION
    People use myAir to self monitor their CPAP treatment.
  • +6 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night.
  • +14 MILLION
    lives changed by a ResMed device, mask or accessory.

See all fast facts

Infographics - Landing Page

Infographics

Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.

 

See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.

Subscribe

 

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages